Works by Muchtar, Eli
Results: 125
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00757-8
- By:
- Publication type:
- Article
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
- By:
- Publication type:
- Article
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00655-z
- By:
- Publication type:
- Article
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00569-2
- By:
- Publication type:
- Article
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
- By:
- Publication type:
- Article
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
- By:
- Publication type:
- Article
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00444-0
- By:
- Publication type:
- Article
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00391-2
- By:
- Publication type:
- Article
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0319-0
- By:
- Publication type:
- Article
Venetoclax for the treatment of translocation (11;14) AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0291-8
- By:
- Publication type:
- Article
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.891712
- By:
- Publication type:
- Article
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-038: Graded cardiac response criteria for AL amyloidosis: the impact of depth of cardiac response on survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02112-1
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
OAB-036: Graded renal response criteria and revised renal progression criteria for light chain (AL) amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S23, doi. 10.1016/S2152-2650(21)02110-8
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
CLL-376: Clinical Characteristics and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL), 80 Years of Age or Older.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S324, doi. 10.1016/S2152-2650(21)01762-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Poster: CLL-376: Clinical Characteristics and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL), 80 Years of Age or Older.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01403-8
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
- By:
- Publication type:
- Article
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e333, doi. 10.1016/j.clml.2019.09.547
- By:
- Publication type:
- Article
Venetoclax For The Treatment of Translocation AL Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e332, doi. 10.1016/j.clml.2019.09.546
- By:
- Publication type:
- Article
Impact of Minimal Residual Negativity on Outcomes in Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e331, doi. 10.1016/j.clml.2019.09.545
- By:
- Publication type:
- Article
Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e305, doi. 10.1016/j.clml.2019.09.501
- By:
- Publication type:
- Article
Clinically significant delay in engraftment with day -1 melphalan prior to stem cell infusion in myeloma patients receiving stem cell transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e301, doi. 10.1016/j.clml.2019.09.495
- By:
- Publication type:
- Article
Venetoclax for the Treatment of Multiple Myeloma: Outcomes Outside of Clinical Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e278, doi. 10.1016/j.clml.2019.09.459
- By:
- Publication type:
- Article
A Hematopoietic Score Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e85, doi. 10.1016/j.clml.2019.09.137
- By:
- Publication type:
- Article
Systemic AL Amyloidosis Myopathy: Presentation, Diagnostic Pitfalls and Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S80, doi. 10.1016/j.clml.2016.07.113
- By:
- Publication type:
- Article
The Impact of Circulating Plasma Cells at Transplant on Survival in Multiple Myeloma in the Era of Novel Agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S78, doi. 10.1016/j.clml.2016.07.109
- By:
- Publication type:
- Article
Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition.
- Published in:
- Annals of Medicine, 2017, v. 49, n. 7, p. 545, doi. 10.1080/07853890.2017.1304649
- By:
- Publication type:
- Article
Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy.
- Published in:
- Acta Haematologica, 2016, v. 135, n. 3, p. 172, doi. 10.1159/000443200
- By:
- Publication type:
- Article
Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 1, p. 39, doi. 10.1159/000354830
- By:
- Publication type:
- Article
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
- By:
- Publication type:
- Article
AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti‐apoptotic BCL2 family members.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8199, doi. 10.1002/cam4.5621
- By:
- Publication type:
- Article
Colon perforation in multiple myeloma patients – A complication of high‐dose steroid treatment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8895, doi. 10.1002/cam4.3507
- By:
- Publication type:
- Article